arrow
A

Alan Landay

university of texas medical branch
H指数:98
被引数:3.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)

一项为期48周的随机对照试验,评估多拉韦林在服用整合酶抑制剂和替诺福韦艾拉酚胺的HIV合并肥胖患者中的疗效:Do IT研究(ACTG A5391)

2026-04-010
PRE
Serum Biomarkers of Macrophage Activation and Incident CKD in People With and Without HIV: Findings From the MACS-WIHS Combined Cohort Study

巨噬细胞活化血清生物标志物与有无HIV人群中新发CKD的关系:MACS-WIHS联合队列研究的结果

2026-04-010
PRE
Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global framework

拓展痴呆风险模型:基于2024年《柳叶刀》委员会报告构建更具包容性的全球框架

2025-09-250
PREAI
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic Vaccination

抗体反应在 Mpox 感染后2年得以维持,但在 Modified Vaccinia Ankara-Bavarian Nordic 疫苗接种后并未出现。

2025-09-010
OAAI
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial

匹他伐他汀对HIV感染者表观遗传衰老生物标志物的影响:REPRIEVE试验的试点亚组研究

2025-06-013
PRE
Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts

循环抗体滴度的特定阈值可预测SARS-CoV-2密切接触者的感染风险及疾病严重程度降低。

2025-05-220
OA
Associations between type III interferons, obesity and clinical severity of COVID-19

III型干扰素、肥胖与COVID-19临床严重程度之间的关系

2025-04-220
OA
Glycation metabolites predict incident age-related comorbidities and mortality in older people with HIV

糖基化代谢物可预测HIV感染者中老年人群新发年龄相关合并症和死亡率。

2025-04-170
OA
Opposite Roles of IL-32α Versus IL-32β/γ Isoforms in Promoting Monocyte-Derived Osteoblast/Osteoclast Differentiation and Vascular Calcification in People with HIV

IL-32α与IL-32β/γ异构体在促进HIV感染者单核细胞来源的成骨细胞/破骨细胞分化及血管钙化中的相反作用

CELLS
IF5.2
2025-03-220
OA
Biomarkers of microbial translocation and generalized inflammation are associated with frailty among people with HIV

微生物易位和全身炎症的生物标志物与艾滋病毒感染者的虚弱有关

AIDS
IF3.1
2024-10-240
PRE